Granite Point Capital Management, L.P. Adicet Bio, Inc. Transaction History

Granite Point Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$5.52 - $9.23 $114,424 - $191,328	20,729 Added 46.06%	65,729 $378,000
Q3 2022 Nov 04, 2022	SELL	$13.43 - $18.74 $2.05 Million - $2.87 Million	-152,898 Reduced 77.26%	45,000 $640,000
Q3 2021 Nov 10, 2021	SELL	$6.29 - $9.93 $238,076 - $375,850	-37,850 Reduced 16.06%	197,898 $1.55 Million
Q2 2021 Aug 16, 2021	SELL	$9.19 - $15.93 $39,075 - $67,734	-4,252 Reduced 1.77%	235,748 $2.43 Million
Q1 2021 May 12, 2021	BUY	$12.12 - $17.17 $2.91 Million - $4.12 Million	240,000 New	240,000 $3.14 Million

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $36M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.